Why Ocera Therapeutics (OCRX) Stock Is Plunging Today

NEW YORK (TheStreet) -- Ocera Therapeutics  (OCRX) plunged Thursday after the company priced its secondary offering of 4.2 million shares of common stock at $6 a share.

The offering will raise gross proceeds of $25.2 million before deduction of the underwriting discount and other offering expenses, Ocera said in a statement. The offering includes a 30-day option for underwriters to purchase up to 630,000 additional shares of common stock, which would result in additional gross proceeds of $3.78 million if fully exercised.

The stock was down 16.69% to $5.94 at 3:38 p.m. More than 1.1 million shares changed hands, which dwarfed the average volume of 46,163.

Must Read: Warren Buffett's 25 Favorite Stocks

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

More from Markets

Red Robin Slumps After Earnings Miss

Red Robin Slumps After Earnings Miss

Stocks Trade Lower as Optimism Wanes Over China Trade Talks

Stocks Trade Lower as Optimism Wanes Over China Trade Talks

Comcast Considering All-Cash Bid for Fox as Disney Battle Heads to the Wire

Comcast Considering All-Cash Bid for Fox as Disney Battle Heads to the Wire

Target's Stock Tanks After Q1 Earnings Miss and Slowing Sales

Target's Stock Tanks After Q1 Earnings Miss and Slowing Sales

Global Rally Stalls as Trump Doubts North Korea Summit, Questions China Trade

Global Rally Stalls as Trump Doubts North Korea Summit, Questions China Trade